(3S)-3-amino-1-(tert-butoxycarbonyl)-pyrrolidine – (147081-44-5)

N-NITROSOMORPHOLINE, 59-89-2, 4-Nitrosomorpholine, Nitrosomorpholine, Morpholine, 4-nitroso-, NMOR, N-Nitrosomorpholin, Morpholine, N-nitroso-, N-Nitrosomorfolin, N-Nitrosomorfolin [Czech], NSC 139, NCI-C02164, 4-Nitroso-morpholine, N-Nitrosomorpholin [German], CCRIS 473, HSDB 4308, UNII-3L25FO7FN7, BRN 0112139, 3L25FO7FN7, DTXSID4021056, CHEBI:76326, NSC-139, DTXCID001056, NSC139, N-NITROSOMORPHOLINE [MI], N-NITROSOMORPHOLINE [HSDB], N-NITROSOMORPHOLINE [IARC], 67587-56-8, N-NITROSOMORPHOLINE (IARC), N-NITROSOMORPHOLIN (GERMAN), CAS-59-89-2, Molsidomine impurity B, NNitrosomorfolin, NNitrosomorpholin, alpha-acetoxy-N-nitrosomorpholine, 4Nitrosomorpholine, N-nitroso morpholine, Morpholine, Nnitroso, Morpholine, 4nitroso, 4-NITOSOMORPHOLINE, N-Nitrosomorpholine solution, WLN: T6N DOTJ ANO, N-Nitrosomorpholine (NMOR), N-Nitrosomorpholine (Standard), CHEMBL165908, SCHEMBL1578515, Tox21_202132, Tox21_302867, MFCD00039710, MSK4918-100M, STL301087, AKOS015903272, MSK4918-1000M, HY-131123R, NCGC00249174-01, NCGC00256343-01, NCGC00259681-01, BS-17191, FN182145, SY052130, 4-Nitrosomorpholine 0.1 mg/ml in Methanol, 4-Nitrosomorpholine 1.0 mg/ml in Methanol, DB-053489, HY-131123, CS-0128913, N0466, NS00010254, C19283, N-Nitrosomorpholine 100 microg/mL in Methanol, T72681, EN300-7323775, N-Nitrosomorpholine Solution in Methanol, 100_g/mL, N-Nitrosomorpholine Solution in Methanol, 1000_g/mL, Q22138414, Z1255360497, Molsidomine impurity B, European Pharmacopoeia (EP) Reference Standard, 627-564-6